Versuchen GOLD - Frei
Converging MedTech with Affordability in 2026
Bio Spectrum
|December 2025
On October 25, the Anusandhan National Research Foundation (ANRF) launched the Mission for Advancement in High-Impact Areas (MAHA)-Medical Technology, in collaboration with the Indian Council of Medical Research (ICMR) and the Gates Foundation. With an objective to accelerate innovation in India's medical technology sector, reduce reliance on high-cost imports, and promote equitable access to affordable and high-quality medical technologies, new doors are opening up for the MedTech sector in 2026, with greater emphasis on startups. Let's take a close look at how the MedTech startups are redefining India's innovation ecosystem.
According to a report launched at the 17th CII Global MedTech Summit 2025, MedTech manufacturing can take the leap towards being a ~$30 billion sector by FY2030, reduce import dependency to less than 50 per cent and increase India's share to 10–12 per cent in the global market. The report also highlights the need to build an accessible innovation ecosystem through partnerships with global hospitals helping accelerate clinical validation for Indian MedTech innovations; and to facilitate global companies to setup 'Co-innovation labs' within MedTech parks in India to accelerate technology transfer, and deepen product R&D. In other words, local innovation can be fostered by promoting in-house capabilities, strengthening industry-academia collaboration and building infrastructure for low-cost prototyping and trials.
The growth of the Indian MedTech sector was also well noticed during the 11th APACMed MedTech Forum, held in September 2025 in Delhi, which was convened outside Singapore for the first time, thereby signalling India's emergence as a critical player in the global MedTech ecosystem. While multiple initiatives are being taken by the government and the industry to strengthen the domestic MedTech sector, the entrepreneurial ecosystem is taking the lead with bold innovations and new risks. As of 2025, India has an estimated 900 to 1,000 startups specifically focused on medical devices and MedTech hardware. However, when we look at the broader MedTech and health-tech landscape, which includes digital health, diagnostics, connected devices, and AI-driven healthcare solutions, the number increases significantly to around 3,000 to 6,000 active startups.
New Trend Setters
Diese Geschichte stammt aus der December 2025-Ausgabe von Bio Spectrum.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Bio Spectrum
Bio Spectrum
Can India's CDMOS Lead the Next Biopharma Wave?
India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).
8 mins
March 2026
Bio Spectrum
Telangana turns catalyst for innovation
Telangana is at a pivotal moment in its journey as a global life sciences hub.
6 mins
March 2026
Bio Spectrum
Is AI the New Weapon in the Fight to End TB?
A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).
2 mins
March 2026
Bio Spectrum
ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India
US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.
1 min
March 2026
Bio Spectrum
Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy
Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.
5 mins
March 2026
Bio Spectrum
"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"
Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.
5 mins
March 2026
Bio Spectrum
Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.
1 min
March 2026
Bio Spectrum
Haleon ropes in Kedar Lele as President for India Subcontinent
Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.
1 min
March 2026
Bio Spectrum
Centre revises Startup Recognition Framework to strengthen Startup India Action Plan
The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.
1 min
March 2026
Bio Spectrum
"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"
In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.
5 mins
March 2026
Listen
Translate
Change font size

